IDEXX LABORATORIES INC /DE Proceeds from Long-term Lines of Credit
IDEXX LABORATORIES INC /DE (IDXX) reported Proceeds from Long-term Lines of Credit of $559.50 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2022-11-01
- IDEXX LABORATORIES INC /DE proceeds from long-term lines of credit for the quarter ending 2022-09-30 was $22.00M.
- IDEXX LABORATORIES INC /DE proceeds from long-term lines of credit for the quarter ending 2022-06-30 was $211.00M.
- IDEXX LABORATORIES INC /DE proceeds from long-term lines of credit for the quarter ending 2022-03-31 was $326.50M.
- IDEXX LABORATORIES INC /DE proceeds from long-term lines of credit for the quarter ending 2021-09-30 was $0.00.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month |
|---|---|---|---|
| 2022-09-30 | $22.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $233.00M derived: sum of 2 quarters · filed 2022-11-01 | $559.50M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $211.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $537.50M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $326.50M 10-Q · filed 2022-05-04 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $0.00 derived: sum of 2 quarters · filed 2022-11-01 | $0.00 10-Q · filed 2022-11-01 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $0.00 10-Q · filed 2022-08-02 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |